Angiography-Derived Physiological Indices for Outcome Prediction in Patients Undergoing OCT-Guided PCI

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-84
SponsorBeijing Anzhen Hospital

About this trial

The primary design of this study is an ambispective observational cohort study. In patients undergoing successful optical coherence tomography (OCT)-guided percutaneous coronary intervention (PCI) with post-procedural angiographic images suitable for computational analysis, this study aims to evaluate the prognostic value of post-PCI angiography-derived physiological indices, specifically angiography-derived fractional flow reserve (Angio-FFR) and angiography-derived index of microcirculatory resistance (Angio-IMR), beyond conventional clinical risk factors and OCT-derived anatomical parameters. Specifically, the objectives are:

1. To determine the associations of post-PCI Angio-FFR and Angio-IMR with the risk of Major Adverse Cardiovascular Events (MACE) during follow-up. 2. To evaluate the incremental prognostic value of post-PCI Angio-FFR and Angio-IMR when added to models incorporating baseline clinical characteristics and OCT-derived anatomical parameters for predicting MACE. 3. To assess whether the combined evaluation of Angio-FFR and Angio-IMR improves identification of residual risk after anatomically optimized, OCT-guided PCI.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

None

Trial population

Adult patients with coronary artery disease undergoing successful OCT-guided PCI with stent implantation at participating centers in China, with post-procedural angiographic images suitable for computation of pre-PPG and post-Angio-FFR and post- Angio-IMR.

Trial design

Design model

Cohort

Time perspective

Other

Treatments tested in this trial

  • OCT-guided PCI

    Procedure/Surgery

    Not applicable as assigned study interventions. This is an observational study. OCT-guided PCI will be performed according to routine clinical practice at each participating center. Coronary angiographic images obtained before and after PCI will be used to derive angiography-based physiologic indices, including pre-PCI pullback pressure gradient (PPG) and post-PCI Angio-FFR and Angio-IMR, for physiologic characterization and outcome analysis.

Treatment groups

1,800 Participants
are divided into 2 treatment groups
Group A: Retrospective cohort1 intervention
Group B: Prospective cohort1 intervention

Trial outcomes

Primary outcomes

1

Major Adverse Cardiovascular Events

MACE is defined as the first occurrence of any of the following events: all-cause death, spontaneous target-vessel myocardial infarction, ischemia-driven target-vessel revascularization, hospitalization for unstable angina, or hospitalization for heart failure.

Time frame
Up to 24 months after the index PCI

Secondary outcomes

1

All-cause death

Occurrence of death from any cause.

Time frame
Up to 24 months after the index PCI
2

Spontaneous target-vessel myocardial infarction

Spontaneous myocardial infarction involving the target vessel. Periprocedural myocardial infarction will not be included.

Time frame
Up to 24 months after the index PCI
3

Ischemia-driven target-vessel revascularization

Repeat revascularization of the target vessel performed because of recurrent ischemia.

Time frame
Up to 24 months after the index PCI
4

Hospitalization for unstable angina

Hospitalization for unstable angina meeting clinical diagnostic criteria.

Time frame
Up to 24 months after the index PCI

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: